Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

Regulatory Landmines in Health Care Litigation: PHI, Kickback, and Corporate Structure Risks [Video]

Дата публикации: 06-10-2026 16:48:20



Основное содержимое страницы с новостью.

Regulatory Landmines in Health Care Litigation: PHI, Kickback, and Corporate Structure Risks [Video]

Watch: What General Counsel and Business Leaders Need to Know
  • Protected Health Information (PHI) in Discovery: PHI must be produced under specific protective orders and in line with both federal and state requirements. Some behavioral health documents require a court order before production, even with a protective order in place.
  • Settlements and Kickback Risk: Settlements with a regulated health care party can raise Anti-Kickback Statute and Stark Law concerns, and a payment to a referral-source physician can be questioned if it overpays the physician to keep referrals coming. Third-party evaluations of settlement value have been used to avoid later improper-payment allegations.
  • Corporate Practice of Medicine: In most states, corporations and hospitals cannot direct how doctors practice. A damage model relying on relationships that violate these rules or other state-law structural issues can fail and create unintended consequences in public filings.

In this episode of Speaking of Litigation®, Epstein Becker Green attorneys Jonathan Brollier, Charles E. Weir, and Megan Thibert-Ind discuss regulatory and business issues unique to the health care industry that can affect how cases are litigated and resolved.

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1ITAR Brokering in Foreign Defense Transactions: DS–4294 Approval, Expanding Enforcement, and Hidden Liability Risks017.1406-10-2026
2Prosecutorial Guidance and Non-Prosecution Policies: A Pragmatic Path Forward for AI in Legal Services017.1418-09-2026
3From State Regulation to Federal Rescheduling: Lessons Learned and the Road Ahead01007-10-2026
4Employee Misconduct: Burden-Shifting Returns with NLRB’s Latest Lion Elastomers021.1107-10-2026
5Baker McKenzie Lawyers Discuss Global Dealmaking Risks as MFN Drug Pricing Policy Reshapes Pharmaceutical Transactions01018-09-2026
6United States: Legal Accountability for AI Agents01001-07-2026
7The (Still) Toothless Nondelegation Doctrine and the Trouble with Second-Best Nondelegation Strategies: FCC v. Consumers’ Research013.1311-09-2026
8United States: Uninsurable Positions - Lessons from Kadau v. Commissioner01004-08-2026
9Графика. Чем опасны ИИ-лекари03506-10-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 10. Источник: www.natlawreview.com.